Abstract
This work presents an empirical and scaling-up study of the degradation and mineralization of amoxicillin (AMX) from expired pharmaceutical formulations by O3-based processes. A set of UV–ozone-based experiments was used to model the kinetics of AMX degradation, considering several chemical/photochemical mechanisms (hydrolysis, direct ozonation, radical reactions, and photolysis). Finally, the modeling data were used for scaling-up purposes, considering CAPEX and OPEX costs on the US Gulf Coast basis. In terms of experimental results, the amoxicillin (AMX) pharmaceutical effluent was successfully degraded by ozone technology at high pH values. The semi-batch ozonation process was effective after 60 min of treatment in all experimental conditions, producing degradation intermediates recalcitrant to O3 oxidative process. From the bench-scale kinetics, scaling-up simulations indicate that the gain provided by adding a UV unit does not compensate for the increase in capital and operational costs of adding irradiation equipment. It suggests ozonation at high pH as the best cost-effective approach to degrade AMX. The figures-of-merit electric energy consumption per order (EEO) corroborates the scaling-up simulations. EEO results indicate no-UV ozonation as the best option to degrade AMX at high pH values. The EEO of the present work showed a lower energy consumption system than previous papers from the literature.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.